Joseph Ravenell on Screening for Colon Cancer in Black Men
Joseph Ravenell, MD, MS, discusses some of the challenges with screening black men for colon cancer.
Joseph Ravenell, MD, MS, assistant professor of Population Health and Medicine, Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, discusses some of the challenges with screening black men for colon cancer.
The incidence and mortality rate from colon cancer is high among black men, according to Ravenell, mainly due to lack of timely screening.
Many men are unaware that they need to be screened, he says, and do not know how to actually get screened.
To clear these hurdles, Ravenell’s group goes out into the community to seek out and educate men who are eligible for screening. The group then aims to educate these men about preparation for colon cancer screening and what to expect.
Addition of Concomitant TTFields Induces OS Benefit in Unresectable Pancreatic Cancer
December 4th 2024The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its primary end point of overall survival in unresectable, locally advanced pancreatic adenocarcinoma.
